IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area.

Ye, Yanyan; Chang, Fangyuan; Xu, Yingchun

Ye, Yanyan; Chang, Fangyuan; Xu, Yingchun.

Afiliación

Ye Y; Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng, 252000, People's Republic of China.
Chang F; Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng, 252000, People's Republic of China.
Xu Y; Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng, 252000, People's Republic of China. XycXyc19830426@163.com.

Cardiovasc Drugs Ther ; 38(3): 419-420, 2024 Jun.

Article en En | MEDLINE | ID: mdl-38294596

Asunto(s)

Aterosclerosis; Interleucina-33; Aterosclerosis/metabolismo; Aterosclerosis/inmunología; Interleucina-33/metabolismo; Humanos; Animales

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Interleucina-33 Límite: Animals / Humans Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google